WallStreetZenWallStreetZen

NYSE: MOH
Molina Healthcare Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for MOH

Based on 11 analysts offering 12 month price targets for Molina Healthcare Inc

Min Forecast
$144.00-10.29%
Avg Forecast
$193.00+20.23%
Max Forecast
$330.00+105.58%

Should I buy or sell MOH stock?

Based on 11 analysts offering ratings for Molina Healthcare Inc.

Hold
Strong Buy
1 analysts 9.09%
Buy
2 analysts 18.18%
Hold
7 analysts 63.64%
Sell
0 analysts 0%
Strong Sell
1 analysts 9.09%
Although MOH's forecast from analysts indicates a "Hold", our proven Zen Rating quant model rates MOH as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their MOH stock forecasts and price targets.

MOH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-12
lockedlocked$00.00+00.00%2025-10-24
lockedlocked$00.00+00.00%2025-10-24
lockedlocked$00.00+00.00%2025-10-24
lockedlocked$00.00+00.00%2025-10-24
Morgan Stanley
Top 6%
95
HoldMaintains$204.00+27.09%2025-10-14
Bernstein
Bottom 11%
11
BuyMaintains$220.00+37.05%2025-09-05
JP Morgan
Bottom 43%
43
HoldMaintains$184.00+14.63%2025-07-29
Truist Securities
Top 11%
90
HoldDowngrades$180.00+12.14%2025-07-25
Baird
Bottom 5%
5
HoldMaintains$179.00+11.51%2025-07-25

1 of 2

Forecast return on equity

Is MOH forecast to generate an efficient return?

Company
30.61%
Industry
23.5%
Market
226.45%
MOH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MOH forecast to generate an efficient return on assets?

Company
8.17%
Industry
7.01%
MOH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MOH earnings per share forecast

What is MOH's earnings per share in the next 3 years based on estimates from 21 analysts?

Avg 1 year Forecast
$14.40-11.08%
Avg 2 year Forecast
$13.57-16.26%
Avg 3 year Forecast
$16.53+2.05%
MOH's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

MOH revenue forecast

What is MOH's revenue in the next 3 years based on estimates from 19 analysts?

Avg 1 year Forecast
$45.2B+1.4%
Avg 2 year Forecast
$47.2B+5.9%
Avg 3 year Forecast
$50.4B+13.21%
MOH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MOH earnings growth forecast

How is MOH forecast to perform vs Healthcare Plans companies and vs the US market?

Company
-0.95%
Industry
32.92%
Market
42.53%
MOH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
MOH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
MOH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

MOH revenue growth forecast

How is MOH forecast to perform vs Healthcare Plans companies and vs the US market?

Company
4.05%
Industry
4.03%
Market
25.86%
MOH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MOH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MOH vs Healthcare Plan Stocks

TickerPricePrice TargetUp/downsideConsensus
MOH$160.52$193.00+20.23%Hold
OSCR$15.59$15.33-1.65%Sell
ALHC$18.91$19.33+2.24%Buy
CLOV$2.66$3.35+25.94%Buy
CNC$38.67$38.67-0.01%Hold
View Top Healthcare Plan Stocks

Molina Healthcare Stock Forecast FAQ

Is Molina Healthcare Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 11 Wall Street analysts covering (NYSE: MOH) stock is to Hold MOH stock.

Out of 11 analysts, 1 (9.09%) are recommending MOH as a Strong Buy, 2 (18.18%) are recommending MOH as a Buy, 7 (63.64%) are recommending MOH as a Hold, 0 (0%) are recommending MOH as a Sell, and 1 (9.09%) are recommending MOH as a Strong Sell.

If you're new to stock investing, here's how to buy Molina Healthcare stock.

What is MOH's earnings growth forecast for 2025-2027?

(NYSE: MOH) Molina Healthcare's forecast annual earnings growth rate of -0.95% is not forecast to beat the US Healthcare Plans industry's average forecast earnings growth rate of 32.92%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.53%.

Molina Healthcare's earnings in 2025 is $883,000,000.On average, 21 Wall Street analysts forecast MOH's earnings for 2025 to be $740,381,020, with the lowest MOH earnings forecast at $680,022,000, and the highest MOH earnings forecast at $995,746,500. On average, 21 Wall Street analysts forecast MOH's earnings for 2026 to be $697,302,680, with the lowest MOH earnings forecast at $554,092,000, and the highest MOH earnings forecast at $782,025,300.

In 2027, MOH is forecast to generate $849,708,820 in earnings, with the lowest earnings forecast at $742,586,080 and the highest earnings forecast at $1,001,143,500.

What is MOH's revenue growth forecast for 2025-2027?

(NYSE: MOH) Molina Healthcare's forecast annual revenue growth rate of 4.05% is forecast to beat the US Healthcare Plans industry's average forecast revenue growth rate of 4.03%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.86%.

Molina Healthcare's revenue in 2025 is $44,550,000,000.On average, 19 Wall Street analysts forecast MOH's revenue for 2025 to be $2,321,892,200,000, with the lowest MOH revenue forecast at $2,140,810,000,000, and the highest MOH revenue forecast at $2,446,948,400,000. On average, 19 Wall Street analysts forecast MOH's revenue for 2026 to be $2,425,052,000,000, with the lowest MOH revenue forecast at $2,259,389,800,000, and the highest MOH revenue forecast at $2,574,934,400,000.

In 2027, MOH is forecast to generate $2,592,359,000,000 in revenue, with the lowest revenue forecast at $2,406,548,000,000 and the highest revenue forecast at $2,879,942,000,000.

What is MOH's forecast return on assets (ROA) for 2025-2028?

(NYSE: MOH) forecast ROA is 8.17%, which is higher than the forecast US Healthcare Plans industry average of 7.01%.

What is MOH's Price Target?

According to 11 Wall Street analysts that have issued a 1 year MOH price target, the average MOH price target is $193.00, with the highest MOH stock price forecast at $330.00 and the lowest MOH stock price forecast at $144.00.

On average, Wall Street analysts predict that Molina Healthcare's share price could reach $193.00 by Nov 12, 2026. The average Molina Healthcare stock price prediction forecasts a potential upside of 20.23% from the current MOH share price of $160.52.

What is MOH's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: MOH) Molina Healthcare's current Earnings Per Share (EPS) is $16.20. On average, analysts forecast that MOH's EPS will be $14.40 for 2025, with the lowest EPS forecast at $13.23, and the highest EPS forecast at $19.37. On average, analysts forecast that MOH's EPS will be $13.57 for 2026, with the lowest EPS forecast at $10.78, and the highest EPS forecast at $15.21. In 2027, MOH's EPS is forecast to hit $16.53 (min: $14.45, max: $19.48).

What is MOH's forecast return on equity (ROE) for 2025-2028?

(NYSE: MOH) forecast ROE is 30.61%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.